Biofourmis
"Biofourmis, a fast-growing global leader in digital therapeutics, discovers, develops and delivers clinically validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, and cost-effective solutions for payers. Biofourmis has built Biovitals™, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics product pipeline across multiple therapeutic areas including heart failure, oncology, acute coronary syndrome, COPD and chronic pain."
Extra Info
Title: Biofourmis | Revolutionize the delivery of care
URL Source: https://www.biofourmis.com/
Published Time: Thu, 04 Sep 2025 20:19:15 GMT
Markdown Content:
Biofourmis | Revolutionize the delivery of care
===============
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
Close
Our company
.svg)
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find open roles Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
What we do
### For care delivery Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### For life science Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find general positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find clinical positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find open roles Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
What we do
### For care delivery Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### For life science Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find general positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find clinical positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find open roles Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
What we do
### For care delivery Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### For life science Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find general positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find clinical positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Vital innovations that bring the right care to everyone, everywhere
With our connected technology platform, we partner with health systems, hospitals, and payers to revolutionize the delivery of care across the care continuum.
Learn more about our solutions
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find open roles Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
What we do
### For care delivery Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### For life science Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
Our company
### About us Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find general positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.### Find clinical positions Massa elit nulla pellentesque eu dictum nisi. Odio morbi integer pharetra sed tristique vitae scelerisque ut.
With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.
Learn more about our solutions
Vital innovations that bring the right care to everyone, everywhere
With our connected technology platform, we partner with health systems, hospitals, and payers to revolutionize the delivery of care across the care continuum.
Learn more about our solutions
With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.
Learn more about our solutions
1
2
Merger Announcement
===================
CopilotIQ and Biofourmis merge to create the first
end-to-end platform for AI-driven in-home care.
Connecting solutions to step up care
Biofourmis addresses challenges impacting the health and pharmaceutical industries today across the continuum from drug development to care delivery. By delivering and transitioning patients across levels of care, clinical trials, and drug companions, our solutions offer patients continuity of care and more care options.Our partners rely on Biofourmis for streamlined services, access to targeted patient populations, and improved economic, operational, and clinical outcomes.
Learn about Biofourmis Platform
Making home the site of care
Our technology-enabled solutions empower patients to receive care at home, and easily transition between levels and locations of care. Outcomes have shown clinical, operational, and economic improvements such as a 70% reduction in 30-day readmissions, the ability to detect deterioration 21 hours sooner, and reductions in cost of care by up to 38%1,2.
01
Hospital at Home
02
Timely Discharge
03
SNF at home
04
Remote Patient Management
Learn more about Biofourmis Care
.webp)
Our collaborators in the healthcare-delivery revolution
We partner with over 50 global health systems and payers to expand access to care and therapeutics in their communities.
Latest
News & Insights
Announcements### ActiGraph Accelerates Clinical Trial Modernization with Transformational Acquisition of Biofourmis Life Science Business
January 7, 2025
Announcements### Biofourmis Selected by AdventHealth to Support “Whole-Person Care” With New Acute Care-at Home Program
January 6, 2025
Announcements### Biofourmis Supports Expansion of Remote Patient Monitoring and Introduction of Home Based Hospital Care at Lee Health
November 18, 2024
Expanding access to care worldwide
We partner with more than 50 health systems and payers to expand access to care in their communities worldwide.
25
U.S. States with licensed operations
Un, KC., Wong, CK., Lau, YM. et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11, 4388 (2021). https://doi.org/10.1038/s41598-021-82771-7.
Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
*Subject to geography and connectivity
Join the revolution
© 2024 Biofourmis. All rights reserved.
Privacy PolicyTerms of ServicePatents
For Care DeliveryAbout UsContact Us
Join the revolution
© 2024 Biofourmis. All rights reserved.
Privacy PolicyTerms of ServicePatents
For Care DeliveryAbout UsContact Us
